Meinhold-Heerlein I - Search Results

1

Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.

Bräutigam K, Bauerschlag DO, Weigel MT, Biernath-Wüpping J, Bauknecht T, Arnold N, Maass N, Meinhold-Heerlein I. Bräutigam K, et al. Transl Oncol. 2009 Aug 18;2(3):164-73. doi: 10.1593/tlo.09121. Transl Oncol. 2009. PMID: 19701501 Free PMC article.

2

Localization of cytokeratin 10 mRNA in human epidermis using nonradioactive in situ hybridization as a routine method.

Meinhold-Heerlein I, Brandstetter T, Kommoss F, Bettendorf H, Hagedorn M, Bauknecht T. Meinhold-Heerlein I, et al. Arch Dermatol Res. 1998 May;290(5):286-8. doi: 10.1007/s004030050306. Arch Dermatol Res. 1998. PMID: 9681682 No abstract available.

3

G-CSF receptor expression in ovarian cancer.

Ninci EB, Brandstetter T, Meinhold-Heerlein I, Bettendorf H, Sellin D, Bauknecht T. Ninci EB, et al. Int J Gynecol Cancer. 2000 Jan;10(1):19-26. doi: 10.1046/j.1525-1438.2000.99076.x. Int J Gynecol Cancer. 2000. PMID: 11240647

4

Evaluation of methods to detect p53 mutations in ovarian cancer.

Meinhold-Heerlein I, Ninci E, Ikenberg H, Brandstetter T, Ihling C, Schwenk I, Straub A, Schmitt B, Bettendorf H, Iggo R, Bauknecht T. Meinhold-Heerlein I, et al. Oncology. 2001;60(2):176-88. doi: 10.1159/000055316. Oncology. 2001. PMID: 11244334

5

Gene therapy of ovarian cancer.

Bauknecht T, Meinhold-Heerlein I. Bauknecht T, et al. Curr Womens Health Rep. 2002 Feb;2(1):39-46. Curr Womens Health Rep. 2002. PMID: 12112982 Review.

6

Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.

von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, Brand-Saberi B. von Kaisenberg CS, et al. Hum Reprod. 2003 Dec;18(12):2544-61. doi: 10.1093/humrep/deg499. Hum Reprod. 2003. PMID: 14645170

7

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.

Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, Orlowska-Volk M, Bauknecht T, Park TW, Jonat W, Jacobsen A, Sehouli J, Luttges J, Krajewski M, Krajewski S, Reed JC, Arnold N, Hampton GM. Meinhold-Heerlein I, et al. Oncogene. 2005 Feb 3;24(6):1053-65. doi: 10.1038/sj.onc.1208298. Oncogene. 2005. PMID: 15558012

8

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.

Meinhold-Heerlein I, Bauerschlag D, Zhou Y, Sapinoso LM, Ching K, Frierson H Jr, Bräutigam K, Sehouli J, Stickeler E, Könsgen D, Hilpert F, von Kaisenberg CS, Pfisterer J, Bauknecht T, Jonat W, Arnold N, Hampton GM. Meinhold-Heerlein I, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):458-66. doi: 10.1158/1078-0432.CCR-06-0691. Clin Cancer Res. 2007. PMID: 17255266

9

[Benign and borderline tumors of the ovary].

Schem Ch, Bauerschlag DO, Meinhold-Heerlein I, Fischer D, Friedrich M, Maass N. Schem Ch, et al. Ther Umsch. 2007 Jul;64(7):369-74. doi: 10.1024/0040-5930.64.7.369. Ther Umsch. 2007. PMID: 17948753 Review. German.

10

Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.

Alkasi O, Meinhold-Heerlein I, Zaki R, Fasching P, Maass N, Jonat W, Beckmann MW. Alkasi O, et al. Arch Gynecol Obstet. 2009 Jan;279(1):57-60. doi: 10.1007/s00404-008-0631-6. Epub 2008 Apr 1. Arch Gynecol Obstet. 2009. PMID: 18379806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page